How to translate text using browser tools
3 July 2024 Pharmacokinetics of Trazodone in Hispaniolan Parrots (Amazona ventralis)
Haley M. Straub, Thomas N. Tully Jr., Levent Dirikolu, Andreas F. Lehner, Justin Zyskowski, John Buchweitz
Author Affiliations +
Abstract

The objective of this study was to establish the pharmacokinetics of a single oral dose of trazodone in the Hispaniolan Amazon parrot (Amazona ventralis). Trazodone is a selective serotonin antagonist and reuptake inhibitor used commonly in both human and veterinary medicine as an antidepressant behavioral modification medicine. A single oral dose of compounded trazodone hydrochloride solution (20 mg/mL) at 50 mg/kg was administered to a total of 7 healthy adult Hispaniolan Amazon parrots. The 7 healthy adult parrots ranged in age from 10 to 15 years and weighed 228 to 323g. Blood was collected at baseline (2 weeks before study) and at 1, 2, 4, 6, 10, and 14 hours post–drug administration. Plasma concentrations of both trazodone and its active metabolite m-chlorophenylpiperazine (mCPP) were measured via liquid chromatography tandem mass spectrometry. Noncompartmental pharmacokinetic analysis was completed. The half-life (t1/2) ± SD of trazodone for the Hispaniolan parrots was 1.89 ± 0.49 hours, and the t1/2 ± SD of mCPP metabolite was 1.9 ± 0.55 hours. Maximum serum drug concentrations, or Cmax (ng/mL), were 738.3 ± 285.3 for trazodone. Times to achieve Cmax (hours) for trazadone and the mCPP metabolite were 1 hour and 2 hours postdosing, respectively. While this study did not establish the behavioral effects of trazodone, no adverse side effects were observed throughout the 48-hour period following drug administration and blood collection. Our results indicate that the oral administration of a 50-mg/kg single dose of trazodone to Hispaniolan parrots may be considered a safe dose. Plasma concentrations are comparable to previously published values in humans, dogs, horses, and pigeons (Columba livia domestica) for up to 14 hours following dosing. This study indicates that further studies are needed to establish the pharmacodynamics and the efficacy of trazodone in the medical management of behavioral problems in psittacine species.

Haley M. Straub, Thomas N. Tully Jr., Levent Dirikolu, Andreas F. Lehner, Justin Zyskowski, and John Buchweitz "Pharmacokinetics of Trazodone in Hispaniolan Parrots (Amazona ventralis)," Journal of Avian Medicine and Surgery 38(2), 98-107, (3 July 2024). https://doi.org/10.1647/AVIANMS-D-23-00047
Published: 3 July 2024
KEYWORDS
Amazona ventralis
Avian
behavioral modification
Hispaniolan Amazon parrots
pharmacokinetic
serotonin antagonist reuptake inhibitor
trazodone
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top